Page 13 - Kbtx Pointed News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Kbtx pointed. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Kbtx Pointed Today - Breaking & Trending Today

Decibel Therapeutics Appoints - GuruFocus.com


®, the first FDA-approved digital medicine.
Bill currently serves as Chairman of the Board of Directors of OPDC and is also the Chairman of the Board of the Sozosei Foundation, a newly established Otsuka charitable organization focused on decriminalization of mental illness. He serves on the boards of Excision BioTherapeutics, Saama and Annexon Biosciences and is Trustee of the non-profit Internet2. He is Board Chair Emeritus of the Sphinx Organization, which advocates for parity and inclusion in the arts.
“Bill is an eminent figure in the biopharmaceutical community with a proven track record of advancing therapies through clinical development, regulatory approval and commercialization. His appointment demonstrates our ambition to establish Decibel at the forefront of innovation in treatments to restore and improve hearing and balance,” said Laurence Reid, Ph.D., Chief Executive Officer. “Bill is passionate about delivering life-changing therapies in areas of unmet ....

United States , Julie Seidel , Abilify Mycite , Annexon Biosciences , Laurence Reid , Chris Railey , Abilify Maintena , American Psychiatric Association , Stern Investor Relations Inc , Leadership Council , Sphinx Organization , Sozosei Foundation , Department Of Psychiatry , Case Western Reserve University School Of Medicine , University Of South Carolina , National Medical Association , Harvard College , Otsuka Pharmaceutical Development Commercialization Inc , Tufts University School Of Medicine , Behavioral Sciences , Otsuka Pharmaceutical Development , Board Chair Emeritus , Chief Executive , Case Western Reserve University School , Tufts University School , Distinguished Fellow ,

SkinBioTherapeutics reports positive consumer feedback for food supplement | 26 May 2021


26 May 2021 | 09:14am
StockMarketWire.com - Skin health focused SkinBioTherapeutics said a study of consumers using one of its food supplements had garnered highly positive feedback.
The AxisBiotix-Ps powered supplement was designed to modulate the immune system by harnessing the gut-skin axis, to address problems associated with sensitive skin conditions such as psoriasis.
A 56-day self-managed consumer study commenced in February with 76% of participants that self-identified as suffering from psoriasis reporting that their skin felt less itchy.
Additionally, 75% reported that their skin appeared less red, 73% reported that their skin felt less irritable and 65% reported that they had fewer flaky patches of skin. ....

Cath Oneill , Skinbiotherapeutics Plc , Catho Neill , Lon Sbtx , Btx L , காத் ஓனேிழில் ,